AARD vs PHM · $284.4M cap vs P/E 7.7, rev $17.95B
Aardvark Therapeutics, Inc. Common Stock (AARD) versus PulteGroup Inc (PHM) — a side-by-side from cached financials, not a winner call.
Aardvark Therapeutics, Inc. Common Stock (AARD) is a biotechnology company listed on US.
PulteGroup Inc (PHM) is a residential construction company listed on US.
AARD does not have a complete income-statement cache yet.
Latest reported PHM revenue for 2024-12-31 was $17.95B. Net income was $3.08B. Revenue was up 11.7% from 2023-12-31 to 2024-12-31. PHM currently screens at market cap $21.92B and trailing P/E 7.7.
AARD currently screens at market cap $284.4M. PHM currently screens at market cap $21.92B and trailing P/E 7.7.
Not investment advice. Open the AARD and PHM stock pages for the full models.
Not investment advice.